Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy
ScienceDaily reports on a study of more than 750,000 pregnancies. It found that early exposure to Ozempic, Wegovy and similar drugs was not linked to increased pregnancy complications when the drugs were used for weight loss, but was associated with a higher risk of premature birth when they were prescribed for diabetes. According to the outlet, the difference suggests diabetes itself may be driving the risk, though researchers caution that the drugs' safety during pregnancy remains uncertain.
Based on ScienceDaily's report - only one outlet has covered this so far. Read the original.Coverage 1 source · 1 report
Chronological.
-
Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy
A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes. The surprising difference suggests that diabetes itself may be driving the risk, although researchers caution that the drugs' safety during pregnancy remains uncertain.
Related stories
Business
Howard Lutnick agrees to testify as bipartisan pressure grows over Nvidia scandal
Sports
Mauricio Pochettino interested in leaving USMNT job for Manchester United
Discussion 0 comments